On Feb. 16 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 12 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA posted more materials from recent virtual public meetings on its 2020 proposed rule on traceability requirements for high risk-foods (see 2009220041), the agency said in a Feb. 12 constituent update. The new materials include a “supply chain example” on how data would be kept and shared in a supply chain for a salad kit. FDA already posted video recordings and transcripts of the three meetings it held on its proposed rule, it said. Comments on the proposal are due Feb. 22 (see 2012170018).
On Feb. 11 the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA has issued its weekly Enforcement Report for Feb. 10, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On Feb. 10, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 9 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 8 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 5 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA recently launched the second phase of its Artificial Intelligence Imported Seafood Pilot program, and will over the next six months apply machine learning technologies in the field as part of its screening processes for seafood imports, the agency said in a constituent update Feb. 8. FDA says it does not anticipate disruptions to importers from the pilot, which began Feb. 1 and is set to run through July 31.